TipRanks
Go Ultimate55% OFF

Silence Therapeutics (SLN) Balance Sheet

Silence Therapeutics Balance Sheet

Silence Therapeutics's total assets for Q2 2026 were $106.41M, a decrease of 7.57% from the previous quarter. SLN total liabilities were $67.94M for the fiscal quarter, a 3.38% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 131.44M$ 161.85M$ 94.53M$ 107.50M$ 96.19M
$ 69.14M$ 54.80M$ 77.12M$ 85.43M$ 87.67M
$ 62.30M$ 107.05M$ 21.99M$ 22.07M$ 8.53M

Currency in GBP

Silence Therapeutics Debt to Assets

060M120M180M0 %40 %80 %120 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets